PubMed · 2003 · 59 citations · 26 references
MedicineOncologyPathologyGastrointestinal OncologyNeoplasiaTumor PathologyImmunohistochemistryMalignant NeoplasmsMalignant TumorsTumor AntigensTumor MarkersTumor-associated AntigensAdenocarcinoma PathologyKi-67 ImmunostainingMetallothionein BiomarkersNeoplastic DiseasePathological CorrelatesPrognostic Marker AssessmentPrognostic Marker EvaluationPrognostic Significance Of Differentiation
The study aimed at determining levels of metallothionein (MT) and Ki-67 antigen expression in adenocarcinomas of large intestine and examining relation of the expression levels with various clinical and pathological variables. The studies were performed on 81 cases of large intestine adenocarcinoma. Using immunocytochemistry, expressions of MT (positive reaction in 73 cases) and of Ki-67 (positive reaction in 79 cases) antigen were examined and the obtained results were compared with, i.a., grade (G) of the tumour and depth to which intestinal wall was infiltrated by individual tumours. Patient survival analysis was also performed, as correlated to expression levels of the two antigens. The obtained results permitted to disclose that the lower was grade of histological differentiation (G2, G3), the more pronounced was expression of MT and Ki-67. Also, the deeper was neoplastic infiltration of intestinal wall, the more pronounced was MT and Ki-67 expression. Despite the relatively strong correlation between MT expression and Ki-67 expression (r=0.536; p<0.05), only Ki-67 antigen expression in large intestine adenocarcinomas was inversely correlated to survival of the patients. Ki-67 proved to be a better prognostic marker, as compared to MT, in large intestine adenocarcinomas.
26
Peter G. Isaacson, Ahmet Doǧan, Stephen K. Price et al. · The American Journal of Surgical Pathology · 1989 · 1.9K citations
Medicine, Endocrinology, Pathology +13
The Spread of Rectal Cancer and its Effect on Prognosis
C E Dukes, H J R Bussey · British Journal of Cancer · 1958 · 807 citations · Full text
Overexpression of Metallothionein Confers Resistance to Anticancer Drugs
Susan L. Kelley, Alakananda Basu, Beverly A. Teicher et al. · Science · 1988 · 605 citations
Medicine, Oncology, Pharmacology +13